[HTML][HTML] Generalisability and potential deaths averted from intensive blood pressure treatment among the elderly population in the US and China: A nationally …
C Li, C Yang, F Shao, X Liang, K Chen… - Journal of Global …, 2023 - ncbi.nlm.nih.gov
Background The Systolic Blood Pressure Intervention Trial (SPRINT) from the US and the
Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial from …
Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial from …
Control of blood pressure and risk of cardiovascular disease and mortality in elderly Chinese: a real-world prospective cohort study
A Wang, X Tian, Y Zuo, S Chen, Y Zhang, X Zhang… - …, 2022 - Am Heart Assoc
Background: The STEP trial (Strategy of Blood Pressure Intervention in the Elderly
Hypertensive Patients) showed that older hypertensive patients might benefit from a target …
Hypertensive Patients) showed that older hypertensive patients might benefit from a target …
[HTML][HTML] Intensive blood pressure control for patients aged over 60: A meta-analysis of the SPRINT, STEP, and ACCORD BP randomized controlled trials
X Li, J Zhang, Z Xing, Q Liu, S Zhou, Y Xiao - Maturitas, 2023 - Elsevier
Objectives To evaluate the effects of intensive treatment to lower blood pressure (BP) on the
risk of cardiovascular disease (CVD) among patients aged over 60 years. Study design We …
risk of cardiovascular disease (CVD) among patients aged over 60 years. Study design We …
[HTML][HTML] Strategy of blood pressure intervention in the elderly hypertensive patients (STEP): Rational, design, and baseline characteristics for the main trial
S Zhang, S Wu, J Ren, X Chen, X Zhang, Y Feng… - Contemporary Clinical …, 2020 - Elsevier
The optimal systolic blood pressure (SBP) treatment target in elderly people is full of
challenge, and non-adherence is one major cause of uncontrolled BP. The Strategy of Blood …
challenge, and non-adherence is one major cause of uncontrolled BP. The Strategy of Blood …
Assessment of long-term benefit of intensive blood pressure control on residual life span: secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT …
M Vaduganathan, BL Claggett, SP Juraschek… - JAMA …, 2020 - jamanetwork.com
Importance High blood pressure (BP) is a leading contributor to premature mortality
worldwide. The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated a 27 …
worldwide. The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated a 27 …
Cost-effectiveness of intensive versus standard blood pressure treatment in older patients with hypertension in China
J Fan, W Zheng, W Liu, J Xu, L Zhou, S Liu, J Bai… - …, 2022 - Am Heart Assoc
Background: In the STEP trial (Strategy of Blood Pressure Intervention in older Hypertensive
Patients), the risk of cardiovascular events is significantly lower in patients who received …
Patients), the risk of cardiovascular events is significantly lower in patients who received …
Intensive Blood Pressure Control and Cardiovascular Outcomes in Elderly Patients: A Secondary Analysis of SPRINT Study Based on a 60-Year Age Cutoff
Background In the original SPRINT article, age was categorized at 75 years, which was
contrary to many previous clinical trials which is at 60 years. Methods The SPRINT trial …
contrary to many previous clinical trials which is at 60 years. Methods The SPRINT trial …
[HTML][HTML] STEP to blood pressure management of elderly hypertension: evidence from Asia
W Zhang, J Cai - Hypertension Research, 2022 - nature.com
With a rapidly aging population, adequate blood pressure (BP) control is critical for
hypertension management and prevention of cardiovascular events. Impressive …
hypertension management and prevention of cardiovascular events. Impressive …
Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial
C Byrne, M Pareek, M Vaduganathan… - European Heart …, 2020 - academic.oup.com
Abstract Aims The 2018 ESC/ESH guidelines for hypertension recommend differential
management of patients who are< 65, 65–79, and≥ 80 years of age. However, it is unclear …
management of patients who are< 65, 65–79, and≥ 80 years of age. However, it is unclear …
Comprehensive treatment of hypertension middle-aged and elderly people: cross-sectional survey data from the China health and retirement longitudinal study …
Background Both drug treatment and non-drug treatment were definitely recommended in
the 2010 Guidelines for Prevention and Treatment of Hypertension in China. This study aims …
the 2010 Guidelines for Prevention and Treatment of Hypertension in China. This study aims …